Although there was no obvious change in the protein level of PAK1 between the control and ATRA treatment groups, an apparent decrease in pPAK1 was observed in HCC cells treated with 20 μM ATRA for 48 h (Fig. 5F). This evidence concerns the gene PAK1 and hepatocellular carcinoma.